Insider · CIK 0001041084
NUDELMAN PHILLIP M PHD
Reports to the SEC for 2 companies · SEATTLE, WA
Transactions
50
Companies
2
Filings
8
CIK
0001041084
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2017-04-29 | CTI BIOPHARMA CORPM Exercise/Conversion | — |
| 2017-04-29 | CTI BIOPHARMA CORPRestricted Stock UnitM Exercise/Conversion | — |
| 2017-02-23 | CTI BIOPHARMA CORPStock Option (right to buy)A Award | — |
| 2016-04-29 | CTI BIOPHARMA CORPM Exercise/Conversion | — |
| 2016-04-29 | CTI BIOPHARMA CORPRestricted Stock UnitM Exercise/Conversion | — |
| 2016-04-29 | CTI BIOPHARMA CORPRestricted Stock UnitA Award | — |
| 2015-12-29 | CTI BIOPHARMA CORPStock Option (right to buy)A Award | — |
| 2015-12-10 | CTI BIOPHARMA CORPD Disposition to Issuer | — |
| 2015-09-30 | CTI BIOPHARMA CORPS Sale | −$197K |
| 2015-09-29 | CTI BIOPHARMA CORPS Sale | −$697.44 |
| 2015-09-29 | CTI BIOPHARMA CORPS Sale | −$1,451 |
| 2015-09-29 | CTI BIOPHARMA CORPS Sale | −$18.7K |
| 2015-09-23 | CTI BIOPHARMA CORPRestricted Stock UnitsA Award | — |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$7,942.5 |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$17.5K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$28.3K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$7,090 |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$46.5K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$21.7K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$29.2K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$24.6K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$713.8 |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$73.2K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$10.4K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$78.3K |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$5,724.42 |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$4,664.085 |
| 2014-03-25 | CTI BIOPHARMA CORPS Sale | −$359 |
| 2014-01-30 | CTI BIOPHARMA CORPA Award | — |
| 2013-12-10 | CTI BIOPHARMA CORPStock Option (right to buy)A Award | — |
| 2013-08-06 | CTI BIOPHARMA CORPS Sale | −$47K |
| 2013-08-06 | CTI BIOPHARMA CORPS Sale | −$7,527.9 |
| 2013-06-26 | CTI BIOPHARMA CORPA Award | — |
| 2013-03-21 | CTI BIOPHARMA CORPD Disposition to Issuer | — |
| 2013-03-21 | CTI BIOPHARMA CORPA Award | — |
| 2013-03-08 | CTI BIOPHARMA CORPS Sale | −$55K |
| 2013-03-08 | CTI BIOPHARMA CORPS Sale | −$19.7K |
| 2013-03-08 | CTI BIOPHARMA CORPS Sale | −$5,671.6 |
| 2013-03-08 | CTI BIOPHARMA CORPS Sale | −$51.2K |
| 2013-03-08 | CTI BIOPHARMA CORPS Sale | −$518 |
| 2013-03-08 | CTI BIOPHARMA CORPS Sale | −$1,430 |
| 2013-03-07 | CTI BIOPHARMA CORPS Sale | −$37.2K |
| 2013-03-07 | CTI BIOPHARMA CORPS Sale | −$12.8K |
| 2013-03-07 | CTI BIOPHARMA CORPS Sale | −$130.8 |
| 2013-03-07 | CTI BIOPHARMA CORPS Sale | −$9,563 |
| 2013-03-07 | CTI BIOPHARMA CORPS Sale | −$394.5 |
| 2012-12-03 | CTI BIOPHARMA CORPA Award | — |
| 2012-06-29 | CTI BIOPHARMA CORPS Sale | −$633.6 |
| 2012-06-29 | CTI BIOPHARMA CORPS Sale | −$7,514 |
| 2012-06-29 | CTI BIOPHARMA CORPS Sale | −$231.6 |
Recent filings
- 4CTI BIOPHARMA CORP0000899243-17-011487SEC(opens sec.gov)
- 4CTI BIOPHARMA CORP0000899243-17-005429SEC(opens sec.gov)
- 4CTI BIOPHARMA CORP0000891293-16-000154SEC(opens sec.gov)
- 4CTI BIOPHARMA CORP0000899243-15-010547SEC(opens sec.gov)
- 4CTI BIOPHARMA CORP0000891293-15-000067SEC(opens sec.gov)
- 4CTI BIOPHARMA CORP0000891293-15-000052SEC(opens sec.gov)
- 4CTI BIOPHARMA CORP0000891293-15-000040SEC(opens sec.gov)
- 4CELL THERAPEUTICS INC0000891293-14-000007SEC(opens sec.gov)
Companies
Address
501 ELLIOTT AVE W., SUITE 400
SEATTLE, WA, 98119